Our novel, patented technology is superior to any competing technology. http://crowncddt.com/
Crown Marketing Inc. (OTCBB: CWNM) has recently patented a controlled drug delivery technology that aims not only to improve the safety and pharmacokinetics of controlled-release medication, but also to streamline the manufacturing process for existing facilities without significantly increasing costs. Crown Marketing is seeking to change the time-release process entirely, providing a true 24-hour sustained-release delivery system.
Crown Marketing has also announced that the smart drug delivery revolution has officially arrived.
Share StructureMarket Value1 $22,618,044 a/o Jan 30, 2013 Shares Outstanding 190,067,600 a/o Nov 14, 2012 Float 67,467,400 Authorized Shares Not Available ShareholdersShareholders of Record 75 a/o Oct 02, 2012